Eupalestin

Overview

Eupalestin is an anti-inflammatory agent. Eupalestin reduces the levels of p-p65 NF-κB and p-p38 MAPK . Eupalestin inhibits MPO and adenosine deaminase . Eupalestin decreases the levels of pro-inflammatory cytokines including IL-17A , IL-6 , TNF and IFN-γ . Eupalestin exerts anti-inflammatory activity in a carrageenan ( HY-125474 )-induced mouse pleurisy model.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > Adenosine Deaminase | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-N8529
• CAS No.: 73340-44-0
• Molecular Formula: C21H20O9
• Molecular Weight: 416.38
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source